Date | Company | Round | Amount | Co-investors |
---|---|---|---|---|
2017-11-14 | ImmusanT | Series C | $40M | ARCH Venture Partners |
2015-06-10 | Melinta Therapeutics | Growth Equity - II | $67M | Malin Corporation |
2014-12-22 | ImmusanT | Series B | $12M | |
2014-02-10 | Melinta Therapeutics | Growth Equity | $70M | |
2013-11-01 | Arisaph Pharmaceuticals | Series F | $10M |